<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Nobel Prize on Tristan Berchoux</title>
    <link>/tags/nobel-prize/</link>
    <description>Recent content in Nobel Prize on Tristan Berchoux</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2019 by Tristan Berchoux</copyright>
    <lastBuildDate>Mon, 17 Dec 2012 15:26:16 +0000</lastBuildDate>
    
	<atom:link href="/tags/nobel-prize/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Should the Cox Proportional Hazards model get the Nobel Prize in Medicine?</title>
      <link>/2012/12/17/should-the-cox-proportional-hazards-model-get-the-nobel-prize-in-medicine/</link>
      <pubDate>Mon, 17 Dec 2012 15:26:16 +0000</pubDate>
      
      <guid>/2012/12/17/should-the-cox-proportional-hazards-model-get-the-nobel-prize-in-medicine/</guid>
      <description>I&amp;rsquo;m not the first one to suggest that Biostatistics has been undervalued in the scientific community, and some of the shortcomings of epidemiology and biostatistics have been noted elsewhere. But this previous work focuses primarily on the contributions of statistics/biostatistics at the purely scientific level.
The Cox Proportional Hazards model is one of the most widely used statistical models in the analysis of data from clinical trials and other medical studies.</description>
    </item>
    
  </channel>
</rss>